ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 77830 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 77830; 2) Community: the network communities that were significantly associated with the response to NSC 77830; 3) Molecule: the relationships between components within communities and NSC 77830; 4) MDR: the compounds that were significantly associated with the NSC 77830.

NSC Compound Enrichment Correlation
NSC 734307 3,4-Dihydroxy-N(3-O-methyl-estra-1,3,5(10)-trien-ol-17b-yl)c innamide 0.0027236921521653 0.37733572
NSC 757113 METHOTREXATE(+/-) 0.0027236921521653 0.59307709
NSC 618759 4-Penten-3-one, 5,5'-(1,4-phenylenbis)bis[2,2-dimethyl- 1-piperidino-, (E,E)-, dihydrobromide 0.00336064452966832 0.40449893
NSC 625492 Bismuth, dichloro(1-piperidinylcarbamodithioato-S,S')-, (T-4)- 0.00336064452966832 0.22650493
NSC 633271 Null 0.00336064452966832 0.32016838
NSC 733755 Null 0.00336064452966832 0.12777785
NSC 756225 GW410563A 0.00336064452966832 -0.22091692
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.00356914129105574 0.47165702
NSC 382034 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- 0.00356914129105574 0.77928314
NSC 654509 Pirarubicin HCl 0.00356914129105574 0.36680891
Total:89  Current:10    [First] [Prev] [Next] [Last]